...
机译:关于预防和治疗糖皮质激素引起的骨质疏松症的药物注册的建议:道德与科学卓越小组的最新动态
Department of Medicine University of Cambridge School of Clinical Medicine Cambridge UK;
University of Aberdeen Medical School Foresterhill Aberdeen AB25 2ZD UK;
Hoffman-La Roche Ltd Basle Switzerland;
Metabolic Bone Unit Laboratory of Molecular Genetics Department of Internal Medicine University of Florence Florence Italy;
International Osteoporosis Foundation Nyon Switzerland;
Sanofi-Aventis Cincinnati USA;
Department of Medicine University of Lyon and INSERM Research Unit 831 Lyon France;
Amgen Thousand Oaks CA USA;
The Arthritis Unit Université Catholique de Louvain Brussels Belgium;
Medicines Disease Center GlaxoSmithKline King of Prussia PA USA;
Laboratory of Physiology and Pharmacology University of Namur Namur Belgium;
Clinical Development UCB Inc. Smyrna GA USA;
Novartis Pharma AG Switzerland;
AGES PharmMed Vienna Austria;
Lilly Research Laboratories Eli Lilly and Company Indianapolis IN USA;
Icelandic Medicines Control Agency Seltjarnarnes Iceland;
Division of Bone Diseases WHO Collaborating Centre for Osteoporosis Prevention Department of Rehabilitation and Geriatrics Geneva University Hospitals and Faculty of Medicine Geneva Switzerland;
Institut de Recherches Internationales Servier Courbevoie France;
General Practice Research Database Medicines and Healthcare Products Regulatory Agency London UK;
Department of Public Health Sciences University of Liège Liège Belgium Chairman GREES Liège Belgium;
Bone mineral density; Bridging study; Glucocorticoid-induced osteoporosis; Men; Phase III studies; Postmenopausal women;
机译:关于预防和治疗糖皮质激素诱导的骨质疏松症的药剂注册的建议:尊重道德和科学卓越小组的最新建议。
机译:关于预防和治疗糖皮质激素引起的骨质疏松症的药物注册的建议:道德与科学卓越小组的最新动态
机译:2014年关于糖皮质激素引起的骨质疏松症的预防和治疗建议的更新
机译:预防和治疗骨质疏松症的骨负荷运动建议
机译:富勒烯-双(双膦酸酯)的体内研究和富勒烯-双膦酸酯-β-阻滞剂缀合物的合成,用于预防和治疗骨质疏松症。
机译:关于治疗骨关节炎的药物注册的建议。尊重道德和科学卓越奖(GREES)小组:骨关节炎科。
机译:关于治疗骨关节炎的药物注册的建议。尊重道德和科学卓越奖(GREES)小组:骨关节炎科。